These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30978192)

  • 1. Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information.
    Keogh RH; Bilton D; Cosgriff R; Kavanagh D; Rayner O; Sedgwick PM
    PLoS One; 2019; 14(4):e0213639. PubMed ID: 30978192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.
    Keogh RH; Szczesniak R; Taylor-Robinson D; Bilton D
    J Cyst Fibros; 2018 Mar; 17(2):218-227. PubMed ID: 29311001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childbearing concerns, information needs and preferences of women with cystic fibrosis: An online discussion group.
    Holton S; Fisher J; Button B; Williams E; Wilson J
    Sex Reprod Healthc; 2019 Mar; 19():31-35. PubMed ID: 30928132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Italian Cystic Fibrosis Registry. Report 2011-2014].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in outcomes of patients with cystic fibrosis.
    Harness-Brumley CL; Elliott AC; Rosenbluth DB; Raghavan D; Jain R
    J Womens Health (Larchmt); 2014 Dec; 23(12):1012-20. PubMed ID: 25495366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire.
    Uchmanowicz I; Jankowska-Polańska B; Wleklik M; Rosinczuk-Tonderys J; Dębska G
    Pneumonol Alergol Pol; 2014; 82(1):10-7. PubMed ID: 24391066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guide to interpreting estimated median age of survival in cystic fibrosis patient registry reports.
    Keogh RH; Stanojevic S
    J Cyst Fibros; 2018 Mar; 17(2):213-217. PubMed ID: 29398488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK.
    Keogh RH; Tanner K; Simmonds NJ; Bilton D
    Sci Rep; 2020 Jun; 10(1):10660. PubMed ID: 32606329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Cystic Fibrosis in Polish Healthcare.
    Rachel M; Topolewicz S; Śliwczyński A; Galiniak S
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden.
    Cameron RA; Office D; Matthews J; Rowley M; Abbott J; Simmonds NJ; Whitty JA; Carr SB
    Chest; 2022 Dec; 162(6):1241-1254. PubMed ID: 35868349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?
    Calthorpe RJ; Smith SJ; Rowbotham NJ; Leighton PA; Davies G; Daniels T; Gathercole K; Allen L; Elliott ZC; Smyth AR
    BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32816834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation.
    Rudolf I; Pieper K; Nolte H; Junge S; Dopfer C; Sauer-Heilborn A; Ringshausen FC; Tümmler B; von Jan U; Albrecht UV; Fuge J; Hansen G; Dittrich AM
    JMIR Mhealth Uhealth; 2019 Nov; 7(11):e12442. PubMed ID: 31750841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis.
    Abbott J; Morton AM; Hurley MA; Conway SP
    BMJ Open; 2015 May; 5(5):e007418. PubMed ID: 25991453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dance of cystic fibrosis: Experiences of living with cystic fibrosis as an adult.
    Varilek BM; Isaacson MJ
    J Clin Nurs; 2020 Sep; 29(17-18):3553-3564. PubMed ID: 32608531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited.
    Jackson AD; Daly L; Kelleher C; Marshall BC; Quinton HB; Foley L; Fitzpatrick P
    J Cyst Fibros; 2011 Jan; 10(1):62-5. PubMed ID: 20888308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Italian Cystic Fibrosis Register - Report 2010].
    Amato A; Ferrigno L; Salvatore M; Toccaceli V;
    Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of patients with cystic fibrosis and caregivers decisions regarding CFTR modulators.
    George A; Smith B; Sawicki GS; Goetz DM
    Pediatr Pulmonol; 2020 Nov; 55(11):2983-2989. PubMed ID: 32589808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping styles in adults with cystic fibrosis: implications for emotional and social quality of life.
    Mc Hugh R; Mc Feeters D; Boyda D; O'Neill S
    Psychol Health Med; 2016; 21(1):102-12. PubMed ID: 25783850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.